Jenburkt Pharma Closes Trading Window for Insider Trading

Jenburkt Pharmaceuticals Limited has announced the closure of its trading window for all designated persons, insiders, and connected individuals, including their relatives. This closure is in effect from July 1, 2026, and will remain open 48 hours after the dissemination of the standalone unaudited financial results for the quarter ending June 30, 2026. The company will separately inform the exchange about the board meeting schedule to consider these financial results.